Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
What’s Next For FDA In Face Of Opposing Mifepristone Injunctions
Apr 09 2023
•
By
Brenda Sandburg
Dueling injunctions stay FDA approval of mifepristone approval and order agency not to alter its availability • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from US FDA
More from Agency Leadership